Genmab(GMAB) - 2025 Q3 - Earnings Call Presentation

Quarter End Results As part of Genmab's First Nine Months 2025 Financial Results presentation, we will discuss several products developed in collaboration with strategic partners or that are the result of product or technology licenses with other companies. This slide is an acknowledgement of those relationships. Period Ended September 30, 2025 © Genmab 2025 Forward looking statement This presentation contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and s ...